SGLT2 Inhibitors Protective Against Retinopathy in T2D SGLT2 Inhibitors Protective Against Retinopathy in T2D

SGLT2 inhibitors are known to reduce diabetic nephropathy risk in patients with type 2 diabetes, but can they also protect against diabetic retinopathy?Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news